Paula, B.d.; Crocamo, S.; de Sousa, C.A.M.; Valverde, P.; Rezende, F.; Abdelhay, E.
Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy. Int. J. Mol. Sci. 2024, 25, 5825.
https://doi.org/10.3390/ijms25115825
AMA Style
Paula Bd, Crocamo S, de Sousa CAM, Valverde P, Rezende F, Abdelhay E.
Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy. International Journal of Molecular Sciences. 2024; 25(11):5825.
https://doi.org/10.3390/ijms25115825
Chicago/Turabian Style
Paula, Bruno de, Susanne Crocamo, Carlos Augusto Moreira de Sousa, Priscila Valverde, Fabiana Rezende, and Eliana Abdelhay.
2024. "Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy" International Journal of Molecular Sciences 25, no. 11: 5825.
https://doi.org/10.3390/ijms25115825
APA Style
Paula, B. d., Crocamo, S., de Sousa, C. A. M., Valverde, P., Rezende, F., & Abdelhay, E.
(2024). Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy. International Journal of Molecular Sciences, 25(11), 5825.
https://doi.org/10.3390/ijms25115825
